<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">nid</journal-id><journal-title-group><journal-title xml:lang="ru">Нефрология и диализ</journal-title><trans-title-group xml:lang="en"><trans-title>Nephrology and Dialysis</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1680-4422</issn><issn pub-type="epub">2618-9801</issn><publisher><publisher-name>Российское диализное общество</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.28996/2618-9801-2018-3-295-311</article-id><article-id custom-type="elpub" pub-id-type="custom">nid-344</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ШКОЛА НЕФРОЛОГА</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>EDUCATIONAL MATERIALS</subject></subj-group></article-categories><title-group><article-title>АА амилоидоз как междисциплинарная проблема - три случая редких заболеваний, осложнившихся системным АА амилоидозом</article-title><trans-title-group xml:lang="en"><trans-title>AA amyloidosis as a multidisciplinary problem - report of three cases of rare diseases, complicated by systemic AA amyloidosis</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Захарова</surname><given-names>Е. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Zakharova</surname><given-names>E. V.</given-names></name></name-alternatives><email xlink:type="simple">helena.zakharova@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Бедин</surname><given-names>В. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Bedin</surname><given-names>V. V.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шутов</surname><given-names>Е. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Shutov</surname><given-names>E. V.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Никитин</surname><given-names>П. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Nikitin</surname><given-names>P. N.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Головинский</surname><given-names>С. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Golovinsky</surname><given-names>S. V.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Милосердов</surname><given-names>И. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Miloserdov</surname><given-names>I. A.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Симонова</surname><given-names>М. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Simonova</surname><given-names>M. S.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Воробьева</surname><given-names>О. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Vorobyova</surname><given-names>O. A.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-3"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ГБУЗ "Городская клиническая больница имени С.П. Боткина" Департамента здравоохранения г. Москвы</institution><country>Россия</country></aff><aff xml:lang="en"><institution>S.P. Botkin City Clinical Hospital, Russian Federation</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ФГБУ "Национальный медицинский исследовательский центр трансплантологии и искусственных органов имени академика В.И. Шумакова" Министерства здравоохранения Российской Федерации</institution><country>Россия</country></aff><aff xml:lang="en"><institution>V.I. Shumakov National Research Center of Transplantology and Artificial Organs</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>ООО "Национальный Центр Клинической Морфологической Диагностики"</institution><country>Россия</country></aff><aff xml:lang="en"><institution>National Centre of Clinical Morphological Diagnostics</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2018</year></pub-date><pub-date pub-type="epub"><day>12</day><month>08</month><year>2024</year></pub-date><volume>20</volume><issue>3</issue><fpage>295</fpage><lpage>311</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Захарова Е.В., Бедин В.В., Шутов Е.В., Никитин П.Н., Головинский С.В., Милосердов И.А., Симонова М.С., Воробьева О.А., 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="ru">Захарова Е.В., Бедин В.В., Шутов Е.В., Никитин П.Н., Головинский С.В., Милосердов И.А., Симонова М.С., Воробьева О.А.</copyright-holder><copyright-holder xml:lang="en">Zakharova E.V., Bedin V.V., Shutov E.V., Nikitin P.N., Golovinsky S.V., Miloserdov I.A., Simonova M.S., Vorobyova O.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://journal.nephro.ru/jour/article/view/344">https://journal.nephro.ru/jour/article/view/344</self-uri><abstract><p>Введение: белком-предшественником АА амилоида является острофазовый белок - сывороточный А-протеин. Спектр заболеваний, осложняющихся развитием АА амилоидоза, достаточно широк, в ряде случаев причиной являются редкие заболевания, диагностика которых представляет значительные трудности. Клинические примеры: мы представляем три случая системного АА амилоидоза, иллюстрирующие трудности диагностики состояний, лежащих в основе этой патологии. Причиной развития АА амилоидоза послужил воспалительный ответ, сопровождающий в первом случае болезнь Кастлемана, во втором случае склерозирующую ангиоматоидную нодулярную трансформацию селезенки, и в третьем случае - муковисцидоз. Во всех случаях основное заболевание характеризовалось многолетним течением с персистирующим хроническим воспалением, важным признаком которого служило, помимо клинических симптомов, значительное повышение уровня СРБ. Диагноз АА амилоидоза, базировавшийся на постепенном формировании нефротического синдрома с прогрессирующей почечной недостаточностью, был подтвержден морфологически. Необратимый характер поражения почек потребовал применения программного гемодиализа, но поскольку хирургическое лечение основного заболевания позволило устранить причину хронического воспаления, а поражение других органов не привело к их функциональной недостаточности, стало возможным выполнение трансплантации почки. Заключение: развитие нефротического синдрома и нарушение функции почек у пациентов с признаками хронического воспаления как известной, так и неуточненной природы, формирует высокий индекс подозрения в отношении АА амилоидоза. Морфологическая верификация диагноза АА амилоидоза необходима для осуществления направленного диагностического поиска его причин, но даже в отсутствие своевременной морфологической диагностики клиническое суждение в ряде случаев позволяет правильно определить тактику ведения больных. Этиологическая разнородность хронических воспалительных процессов, лежащих в основе АА амилоидоза, требует мультидисциплинарного подхода с участием представителей различных терапевтических и хирургических специальностей. Редкость некоторых заболеваний, осложняющихся развитием АА амилоидоза, создает значительные диагностические трудности, и только совместная работа хирургов и интернистов может обеспечить адекватную диагностику и успешное поэтапное лечение.</p></abstract><trans-abstract xml:lang="en"><p>Introduction: АА amyloid precursor is serum amyloid A protein, produced in response to the cytokine stimulation. The broad spectrum of the diseases with quite different etiology and pathogenesis may be eventually compicated by AA amyloidosis, in some cases these are rare diseases, presenting difficulties for diagnostics. Case presentation: we present three cases of systemic AA amyloidosis, illustrating the difficulties in diagnostics of the underlying diseases. AA amyloidosis complicated prolonged chronic inflammation in patients with Castleman’s disease, sclerosing angiomatoid nodular transformation of spleen (SANT), and cystic fibrosis. In all cases the disease had a prolonged course with persistent chronic inflammation, presenting with non-specific clinical features and highly elevated C-reactive protein level. AA amyloidosis diagnostics based on the gradual development of nephrotic syndrome with impaired kidney function was confirmed by histology. End stage of renal disease demanded hemodialysis, however, surgical removal of the source of inflammation and absence of other organs dysfunction gives an opportunity to offer kidney transplantation. Conclusions: nephrotic syndrome and impaired kidney function in patients with signs and symptoms of chronic inflammation, regardless of its known or unknown origin, provide the high suspicion index for AA amyloidosis. Pathology confirmation is crucial; however even in the absence of timely pathology diagnostics clinical judgment in some cases gives a guidance for work-up and treatment. Different etiology of chronic inflammatory conditions, leading to AA amyloidosis, demands multidisciplinary approach. Rarity of the described conditions leads to the substantial difficulties for diagnostics; therefore only collaboration between the representatives of different specialties ensures adequate diagnostics and successful treatment.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>почки</kwd><kwd>болезнь Кастлемана</kwd><kwd>склерозирующая ангиоматоидная нодулярная трансформация селезенки</kwd><kwd>муковисцидоз</kwd><kwd>АА amyloidosis</kwd><kwd>kidneys</kwd><kwd>Castleman’s disease</kwd><kwd>sclerosing angiomatoid nodular transformation</kwd><kwd>cystic fibrosis</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Sipe J.D., Benson M.D., Buxbaum J.N., Ikeda S., Merlini G., Saraiva M.J., Westermark P. Nomenclature 2014: amyloid fibril proteins and clinical classification of the amyloidosis. Amyloid. 2014; 21(4): 221-224. doi: 10.3109/13506129.2014.964858</mixed-citation><mixed-citation xml:lang="en">Sipe J.D., Benson M.D., Buxbaum J.N., Ikeda S., Merlini G., Saraiva M.J., Westermark P. Nomenclature 2014: amyloid fibril proteins and clinical classification of the amyloidosis. Amyloid. 2014; 21(4): 221-224. doi: 10.3109/13506129.2014.964858</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Said S.M., Sethi S., Valeri A.M., Leung N., Cornell L.D., Fidler M.E., Herrera Hernandez L., Vrana J.A., Theis J.D., Quint P.S., Dogan A., Nasr S.H. Renal amyloidosis: origin and clinicopatholpgic correlations of 474 recent cases. Clin J Am soc Nephrol. 2013;8: 1515-1523</mixed-citation><mixed-citation xml:lang="en">Said S.M., Sethi S., Valeri A.M., Leung N., Cornell L.D., Fidler M.E., Herrera Hernandez L., Vrana J.A., Theis J.D., Quint P.S., Dogan A., Nasr S.H. Renal amyloidosis: origin and clinicopatholpgic correlations of 474 recent cases. Clin J Am soc Nephrol. 2013;8: 1515-1523</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Picken M.M., Dogan A. Amyloidosis of the Kidney, the Lower Urinary and Genital Tract IMale and female) and the Breast. In Amyloid and Related Disorders. Ed Picken M.M., Herrera G.A., Dogan A. Humana Press (Springer) 2015: 369-390</mixed-citation><mixed-citation xml:lang="en">Picken M.M., Dogan A. Amyloidosis of the Kidney, the Lower Urinary and Genital Tract IMale and female) and the Breast. In Amyloid and Related Disorders. Ed Picken M.M., Herrera G.A., Dogan A. Humana Press (Springer) 2015: 369-390</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Lachmann H.J., Goodman H.J.B., Gilbertson A.J., Gallimore J.R., Sabin S.A., Gillmore J.D., Hawkins P.N. Natural history and outcome in systemic AA amyloidosis. N Engl J Med. 2007;356: 2361-2371</mixed-citation><mixed-citation xml:lang="en">Lachmann H.J., Goodman H.J.B., Gilbertson A.J., Gallimore J.R., Sabin S.A., Gillmore J.D., Hawkins P.N. Natural history and outcome in systemic AA amyloidosis. N Engl J Med. 2007;356: 2361-2371</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Obici L., Merlini G. AA amyloidosis: Basic knowledge, unmet needs and future treatments. Swiss medical weekly. 2012;31: 142. DOI: 10.4414/smw.2012.13580</mixed-citation><mixed-citation xml:lang="en">Obici L., Merlini G. AA amyloidosis: Basic knowledge, unmet needs and future treatments. Swiss medical weekly. 2012;31: 142. DOI: 10.4414/smw.2012.13580</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Ombrello A.K., Aksentijevich I. AA Amyloidosis. In Amyloid and Related Disorders. Ed Picken M.M., Herrera G.A., Dogan A. Humana Press (Springer) 2015: 31-54</mixed-citation><mixed-citation xml:lang="en">Ombrello A.K., Aksentijevich I. AA Amyloidosis. In Amyloid and Related Disorders. Ed Picken M.M., Herrera G.A., Dogan A. Humana Press (Springer) 2015: 31-54</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Castleman B., Iverson L., Menendez V.P. Localized mediastinal lymphnode hyperplasia resembling thymoma. Cancer. 1956;(4):822-830</mixed-citation><mixed-citation xml:lang="en">Castleman B., Iverson L., Menendez V.P. Localized mediastinal lymphnode hyperplasia resembling thymoma. Cancer. 1956;(4):822-830</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Munshi N., Mehra M., van de Velde H., Desai A., Potluri R., Vermeulen J. Use of a claims database to characterize and estimate the incidence rate for Castleman disease. Leuk Lymphoma. 2015;56: 1252-1260</mixed-citation><mixed-citation xml:lang="en">Munshi N., Mehra M., van de Velde H., Desai A., Potluri R., Vermeulen J. Use of a claims database to characterize and estimate the incidence rate for Castleman disease. Leuk Lymphoma. 2015;56: 1252-1260</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Cronin D.M., Warnke R.A. Castleman disease: an update on classification and the spectrum of associated lesions. Adv Anat Pathol. 2009;16: 236-246</mixed-citation><mixed-citation xml:lang="en">Cronin D.M., Warnke R.A. Castleman disease: an update on classification and the spectrum of associated lesions. Adv Anat Pathol. 2009;16: 236-246</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Lachmann H.J., Gilbertson J.A., Gillmore J.D., Hawkins P.N., Pepys M.B. Unicentric Castleman's disease complicated by systemic AA amyloidosis: a curable disease. Q J Med. 2002; 95 (4): 211-218</mixed-citation><mixed-citation xml:lang="en">Lachmann H.J., Gilbertson J.A., Gillmore J.D., Hawkins P.N., Pepys M.B. Unicentric Castleman's disease complicated by systemic AA amyloidosis: a curable disease. Q J Med. 2002; 95 (4): 211-218</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">El Karoui K., Vuiblet V., Dion D. et al. Renal involvement in Castleman disease. Nephrol Dial Transplant. 2011; 26(2): 599-609</mixed-citation><mixed-citation xml:lang="en">El Karoui K., Vuiblet V., Dion D. et al. Renal involvement in Castleman disease. Nephrol Dial Transplant. 2011; 26(2): 599-609</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Gaduputi V., Tariq H., Badipatla K., Ihimoyan A. Systemic Reactive Amyloidosis Associated with Castleman's Disease. Case Rep Gastroenterol. 2013;7(3): 476-481. doi: 10.1159/00035682</mixed-citation><mixed-citation xml:lang="en">Gaduputi V., Tariq H., Badipatla K., Ihimoyan A. Systemic Reactive Amyloidosis Associated with Castleman's Disease. Case Rep Gastroenterol. 2013;7(3): 476-481. doi: 10.1159/00035682</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Curioni S., D’Amico M., Quartagano R., Martino S., Dell’Antonio G., Cusi D. Castleman's disease with nephrotic syndrome, amyloidosis and autoimmune manifestations. Nephrol Dyal Transplant. 2001;16(7): 1475-1478</mixed-citation><mixed-citation xml:lang="en">Curioni S., D’Amico M., Quartagano R., Martino S., Dell’Antonio G., Cusi D. Castleman's disease with nephrotic syndrome, amyloidosis and autoimmune manifestations. Nephrol Dyal Transplant. 2001;16(7): 1475-1478</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Martel M., Cheuk W., Lombardi L., Lifschitz-Mercer B., Chan J.K., Rosai J. Sclerosing angiomatoid nodular transformation (SANT): report of 25 cases of a distinctive benign splenic lesion. Am J Surg Pathol. 2004; 28: 1268-1279</mixed-citation><mixed-citation xml:lang="en">Martel M., Cheuk W., Lombardi L., Lifschitz-Mercer B., Chan J.K., Rosai J. Sclerosing angiomatoid nodular transformation (SANT): report of 25 cases of a distinctive benign splenic lesion. Am J Surg Pathol. 2004; 28: 1268-1279</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Wang T-B., Hu B-G., Liu D-W., Gao Z.H., Shi H.P., Dong W.G. Sclerosing angiomatoid nodular transformation of the spleen: A case report and literature review. Oncology Letters. 2016;12: 928-932</mixed-citation><mixed-citation xml:lang="en">Wang T-B., Hu B-G., Liu D-W., Gao Z.H., Shi H.P., Dong W.G. Sclerosing angiomatoid nodular transformation of the spleen: A case report and literature review. Oncology Letters. 2016;12: 928-932</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Nagai Y., Satoh D., Matsukawa H., Shiozaki S. Sclerosing angiomatoid nodular transformation of the spleen presenting rapid growth after adrenalectomy: Report of a case. International Journal of Surgery Case Reports. 2017;30: 108-111</mixed-citation><mixed-citation xml:lang="en">Nagai Y., Satoh D., Matsukawa H., Shiozaki S. Sclerosing angiomatoid nodular transformation of the spleen presenting rapid growth after adrenalectomy: Report of a case. International Journal of Surgery Case Reports. 2017;30: 108-111</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Önder S., Kosemehmetoglu K., Himmetoglu C., Firat P., Uner A. Sclerosing angiomatoid nodular transformation (SANT) of spleen: a case report describing cytology, histology, immunoprofile and differential diagnosis. Cytology. 2012;23:129-132</mixed-citation><mixed-citation xml:lang="en">Önder S., Kosemehmetoglu K., Himmetoglu C., Firat P., Uner A. Sclerosing angiomatoid nodular transformation (SANT) of spleen: a case report describing cytology, histology, immunoprofile and differential diagnosis. Cytology. 2012;23:129-132</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Kashiwagi S., Kumasaka T., Bunsei N., Fukumura Y., Yamasaki S., Abe K. Detection of Epstein-Barr virus-encoded small RNA-expressed myofibroblasts and IgG4-producing plasma cells in sclerosing angiomatoid nodular transformation of the spleen. Virchows Arch. 2008; 453:275-282</mixed-citation><mixed-citation xml:lang="en">Kashiwagi S., Kumasaka T., Bunsei N., Fukumura Y., Yamasaki S., Abe K. Detection of Epstein-Barr virus-encoded small RNA-expressed myofibroblasts and IgG4-producing plasma cells in sclerosing angiomatoid nodular transformation of the spleen. Virchows Arch. 2008; 453:275-282</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Said S.M., Leung N., Sethi S., Cornell L.D., Fidler M.E., Grande J.P., Herrmann S., Tefferi A., D'Agati V.D., Nasr S.H. Myeloproliferative neoplasms cause glomerulopathy. Kidney International. 2011;80: 753-759</mixed-citation><mixed-citation xml:lang="en">Said S.M., Leung N., Sethi S., Cornell L.D., Fidler M.E., Grande J.P., Herrmann S., Tefferi A., D'Agati V.D., Nasr S.H. Myeloproliferative neoplasms cause glomerulopathy. Kidney International. 2011;80: 753-759</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Jhaveri K.D., Shah H.H., Calderon K., Campenot ES, Radhakrishnan J. Glomerular diseases seen with cancer and chemotherapy: a narrative review. Kidney International. 2013;84: 34-44</mixed-citation><mixed-citation xml:lang="en">Jhaveri K.D., Shah H.H., Calderon K., Campenot ES, Radhakrishnan J. Glomerular diseases seen with cancer and chemotherapy: a narrative review. Kidney International. 2013;84: 34-44</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Pallante A.J., Leung N., Kyle R.A., Tefferi A., Russell S.J., Habermann T.M., Lacy M.Q., Hayman S.R., Al-Kali A., Reeder C., Dispenzieri A., Gertz M.A., Buadi F.K., Hook C.C., Dingli D., Pardanani A. Concomitant Myeloproliferative Disorders and Amyloidosis. Blood. 2016;128: 54-80</mixed-citation><mixed-citation xml:lang="en">Pallante A.J., Leung N., Kyle R.A., Tefferi A., Russell S.J., Habermann T.M., Lacy M.Q., Hayman S.R., Al-Kali A., Reeder C., Dispenzieri A., Gertz M.A., Buadi F.K., Hook C.C., Dingli D., Pardanani A. Concomitant Myeloproliferative Disorders and Amyloidosis. Blood. 2016;128: 54-80</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Kim H.H., Hur Y.H., Koh Y.S., Kim J.C., Kim H.J., Kim J.W. Sclerosing angiomatoid nodular transformation of the spleen related to IgG4-associated disease: report of a case, Surg. Today 2013;43: 930-936</mixed-citation><mixed-citation xml:lang="en">Kim H.H., Hur Y.H., Koh Y.S., Kim J.C., Kim H.J., Kim J.W. Sclerosing angiomatoid nodular transformation of the spleen related to IgG4-associated disease: report of a case, Surg. Today 2013;43: 930-936</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Zakharova E.V., Shutov E.V., Vorobyova O.A., Nikitin E.A. AA amyloidosis in a patient with essential thrombocythemia and sclerosing angiomatoid nodular transformation of the spleen. J Onco-Nephrol. 2017;1(3): 13-17. DOI: 10.5301/jo-n.5000028</mixed-citation><mixed-citation xml:lang="en">Zakharova E.V., Shutov E.V., Vorobyova O.A., Nikitin E.A. AA amyloidosis in a patient with essential thrombocythemia and sclerosing angiomatoid nodular transformation of the spleen. J Onco-Nephrol. 2017;1(3): 13-17. DOI: 10.5301/jo-n.5000028</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">O'Sullivan B.P., Freedman S.D. Cystic fibrosis. Lancet. 2009;373(9678): 1891-904 doi:10.1016/s0140-6736(09)60327-5. PMID 19403164.</mixed-citation><mixed-citation xml:lang="en">O'Sullivan B.P., Freedman S.D. Cystic fibrosis. Lancet. 2009;373(9678): 1891-904 doi:10.1016/s0140-6736(09)60327-5. PMID 19403164.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Hodson M., Geddes D., Bush A. Eds. Cystic fibrosis. 2012 (3rd ed.). London, Hodder Arnold. 486 pages. ISBN 978-1-4441-1369-3</mixed-citation><mixed-citation xml:lang="en">Hodson M., Geddes D., Bush A. Eds. Cystic fibrosis. 2012 (3rd ed.). London, Hodder Arnold. 486 pages. ISBN 978-1-4441-1369-3</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Mitchell R.S., Kumar V., Robbins S.L., Abbas A.K., Fausto N. ROBBINS Basic Pathology. 2007. Saunders/Elsevier. 946 pages. ISBN 1-4160-2973-7.</mixed-citation><mixed-citation xml:lang="en">Mitchell R.S., Kumar V., Robbins S.L., Abbas A.K., Fausto N. ROBBINS Basic Pathology. 2007. Saunders/Elsevier. 946 pages. ISBN 1-4160-2973-7.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Mc Laughlin A.M., Crotty T.B., Egan J.J., Watson A.J., Gallagher C.G. Amyloidosis in cystic fibrosis: a case series. J Cyst Fibros. 2006;5:59-61</mixed-citation><mixed-citation xml:lang="en">Mc Laughlin A.M., Crotty T.B., Egan J.J., Watson A.J., Gallagher C.G. Amyloidosis in cystic fibrosis: a case series. J Cyst Fibros. 2006;5:59-61</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Gottlieb J., Ballmann M., VonMallinckrodt C., Staab D., Smaczny C., Simon A., Welte T., Wagner T.O. Lung transplantation in cystic fibrosis - a position paper. Pneumologie. 2009;63(8):451-460</mixed-citation><mixed-citation xml:lang="en">Gottlieb J., Ballmann M., VonMallinckrodt C., Staab D., Smaczny C., Simon A., Welte T., Wagner T.O. Lung transplantation in cystic fibrosis - a position paper. Pneumologie. 2009;63(8):451-460</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Braun A.T., Merlo C.A. Cystic fibrosis lung transplantation. Current Opinion in Pulmonary Medicine. 2011;17(6): 467-472</mixed-citation><mixed-citation xml:lang="en">Braun A.T., Merlo C.A. Cystic fibrosis lung transplantation. Current Opinion in Pulmonary Medicine. 2011;17(6): 467-472</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Kaplan B., Qazi Y., Wellen J.R. Strategies for the management of adverse events associated with mTOR inhibitors. Transplantation Reviews. 2014; 28: 126-133</mixed-citation><mixed-citation xml:lang="en">Kaplan B., Qazi Y., Wellen J.R. Strategies for the management of adverse events associated with mTOR inhibitors. Transplantation Reviews. 2014; 28: 126-133</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
